Arkolith/Insider Trading/ATRS/Form 4

Richardson Peter C

See RemarksANTARES PHARMA, INC. (ATRS) · full profile →Form 4 · filed May 26, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 24, 2022Disposed to issuer(D)14K$5.60$81K0
May 24, 2022Disposed to issuer(D)36K$5.60$203K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 24, 2022Disposed to issuer(D)69K——0
May 24, 2022Disposed to issuer(D)59K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-019794) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML